Sodium valproate: its use in primary psychiatric disorders

Area of Science:

• Psychiatry
• Pharmacology
• Neurology

Background:

• Sodium valproate is recognized for treating recurrent major affective and schizoaffective disorders.
• Investigating valproate's efficacy in a broader psychiatric patient cohort is warranted.

Purpose of the Study:

• To retrospectively review the effectiveness of sodium valproate in psychiatric patients.
• To identify predictors of a positive response to valproate treatment.

Main Methods:

• Retrospective chart review of 36 psychiatric patients treated with valproate.
• Exclusion of patients with neurological disorders or paroxysmal EEG activity.
• Analysis of diagnostic categories and EEG findings in relation to treatment response.

Main Results:

• 44% (16 of 36) of patients showed a moderate to marked response to valproate.
• Favorable responses were associated with diagnoses of bipolar or schizoaffective disorder.
• Non-paroxysmal electroencephalogram (EEG) abnormalities also predicted a positive outcome.

Conclusions:

• Sodium valproate demonstrates potential as a treatment for major affective disorder.
• Bipolar disorder and specific EEG patterns may indicate better valproate efficacy.
• Further research into valproate for affective disorders is recommended.